Point-of-Care Diagnostics Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Increasing prevalence of infectious diseases across the world and changing healthcare practice environment is expected to drive the point-of-care diagnostics market growth.
Point-of-Care Diagnostics Market is valued at USD 22688.6 Million in 2018 and expected to reach USD 46308.9 Million by 2025 with the CAGR of 10.73% over the forecast period.
Point-of-care testing diagnostics (POCD) refers to the rapid detection of diseases near to patient, which provides an appropriate diagnosis, monitoring and management. Potentially it offers fast medical treatment to improve health outcome of patients to cure medical conditions. Consequently, POCD can be integrated with healthcare system to provide laboratory testing outside of the main laboratory with dedicated clinical settings. Recent advancements in point of care diagnostics have made testing easier that can be performed by moderately trained staff and require less human interaction. For example, sensor technologies is used to perform rapid testing of blood samples for many critical assays, where biosensors are used for drug screening, appropriate measurement of blood cells, detection of cardiac markers and glucose testing.
Global Point-of-Care Diagnostics Market report is segmented on the testing, by mode, end-users and by regional & country level. Based upon testing, global point-of-care diagnostics market is segmented as glucose testing, infectious disease, blood gas electrolyte, cardiac biomarker, coagulation, cholesterol, pregnancy, drugs of abuse, urinalysis, and hematology and other. Furthermore, based upon mode, point-of-care diagnostics market is segmented into prescription-based testing and OTC-based testing. Based on end-users, market is classified into hospitals and clinics, homecare settings and diagnostic centers.
Point-of-Care Diagnostics Market is valued at USD 22688.6 Million in 2018 and expected to reach USD 46308.9 Million by 2025 with the CAGR of 10.73% over the forecast period.
Point-of-care testing diagnostics (POCD) refers to the rapid detection of diseases near to patient, which provides an appropriate diagnosis, monitoring and management. Potentially it offers fast medical treatment to improve health outcome of patients to cure medical conditions. Consequently, POCD can be integrated with healthcare system to provide laboratory testing outside of the main laboratory with dedicated clinical settings. Recent advancements in point of care diagnostics have made testing easier that can be performed by moderately trained staff and require less human interaction. For example, sensor technologies is used to perform rapid testing of blood samples for many critical assays, where biosensors are used for drug screening, appropriate measurement of blood cells, detection of cardiac markers and glucose testing.
Global Point-of-Care Diagnostics Market report is segmented on the testing, by mode, end-users and by regional & country level. Based upon testing, global point-of-care diagnostics market is segmented as glucose testing, infectious disease, blood gas electrolyte, cardiac biomarker, coagulation, cholesterol, pregnancy, drugs of abuse, urinalysis, and hematology and other. Furthermore, based upon mode, point-of-care diagnostics market is segmented into prescription-based testing and OTC-based testing. Based on end-users, market is classified into hospitals and clinics, homecare settings and diagnostic centers.
Key Players for Point-of-Care Diagnostics Market Report–Some major key players for global Point-of-Care Diagnostics market are Abbott Laboratories, Becton Dickinson & Co, Bio-Rad Laboratories, Inc, Trinity Biotech, Accubiotech, Quidel, Danaher, F. Hoffmann-La Roche Ltd, Nova Biomedical, Dickinson and Company and Others.
Point-of-Care Diagnostics Market Segmentation-:By Testing
Point-of-Care Diagnostics Market Segmentation-:By Testing
- Glucose testing
- Infectious disease
- Blood gas electrolyte
- Cardiac biomarker
- Coagulation
- Cholesterol
- Pregnancy
- Drugs of abuse
- Urinalysis
- Hematology
- Other
- Prescription-based Testing
- OTC-based Testing
- Hospitals and Clinics
- Homecare Settings
- Diagnostic Centers